Summary
An association between increased tolerance to pain and arterial hypertension has been reported in experimental animals and confirmed in humans. The underlying mechanisms remain elusive. We have recently reported that diuretics and beta-blocking treatment do not influence pain sensitivity, despite significant reductions in arterial blood pressure. In the present study, ketanserin was evaluated. As in previous work, pain perception was assessed with a tooth pulp tester. Ten hypertensive subjects were studied basally, after 15 days and after 3 months of ketanserin treatment (20 mg twice daily). Significant reduction in arterial blood pressure and of pain thresholds were observed, but no correlation between these changes occurred. These preliminary data indicate that, contrary to other hypotensive drugs, ketanserin tends to decrease or reverse the abnormality in pain modulation observed in hypertensive patients. The lack of a correlation between effects on blood pressure and pain sensitivity seems, however, to favor the hypothesis of two independent underlying mechanisms.
Similar content being viewed by others
References
Zamir N, Segal M. Hypertension-induced analgesia: Changes in pain sensitivity in experimental hypertensive rats. Brain Res 1979;160:170–173.
Saavedra JM. Naloxone reversible decrease in pain sensitivity in young and adult spontaneously hypertensive rats. Brain Res 1981;209:245–249.
Sitsen JMA, de Jong W. Observations on pain perception and hypertension in spontaneously hypertensive rats. Clin Exp Hypertens 1984;A6(7):1345–1356.
Zamir N, Shuber E. Altered pain perception in hypertensive humans. Brain Res 1980;201:471–474.
Ghione S, Rosa C, Mezzasalma L, Panattoni E. Arterial hypertension is associated with hypoalgesia in humans. Hypertension 1988;12:491–497.
Vignocchi G, Murri L, Rossi B, Rosa C, Ghione S. Correlation between pain thresholds and polysynaptic components of blink reflex in essential arterial hypertension. Functional Neurol 1989;4:59–61.
Vanhoutte P, Amery A, Birkenhäger W, et al. Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin. Hypertension 1988;11:111–133.
Fields HL, Basabaum AI. Brainstem control of spinal pain transmission neurons. Ann Rev Physiol 1978;40:217–248.
Sandrini G, Alfonsi E, De Rysky C, et al. Evidence for serotonin S2 receptor involvement in analgesia in humans. Eur J Pharmacol 1986;130:311–314.
Laduron PM, Janssen PFM, Leysen JE. In vivo binding of [3H] ketanserin on S2 receptor in rat brain. Eur J Pharmacol 1982;81:43–48.
Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PFM, Laduron PM. Receptor binding properties in vivo and in vitro of ritanserin, a very potent and long acting serotonin S2 antagonist. Mol Pharmacol 1985; 27:600–611.
Zamir N, Maixner W. The relationship between cardiovascular and pain regulatory systems. Ann NY Acad Sci 1986;467:371–384.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosa, C., Ghione, S. Effect of ketanserin on pain perception in arterial hypertension. Cardiovasc Drug Ther 4, 133–135 (1990). https://doi.org/10.1007/BF00053445
Issue Date:
DOI: https://doi.org/10.1007/BF00053445